Jakarta, CNBC Indonesia – Government either Widodo through Spokesmen of Handling Task Force Covid-19 Wiku Adisasmito report positive news on the development of the corona virus vaccine (Covid-19) in Indonesia. Making the vaccine accelerated so that it can be used immediately.
Wiku said there had been several collaborative initiatives undertaken by Indonesia to speed up the corona vaccine.
“One of them is Bio Farm and Sinovac “which is currently in phase three clinical trials and is expected to be completed in sufficient time so that production is immediately carried out,” he said in a digital press conference this week.
“Besides Bio Farm there are also plans with the private sector, viz Kalbe Farm. We want vaccine production produced by Indonesian companies. “
PT Bio Farm (Persero) is a pharmaceutical holding BUMN that oversees three pharmaceutical companies on the Indonesia Stock Exchange (AT) i.e. PT Indofarma Tbk (INAF), PT Kimia Farm Tbk (KAEF), and PT Phapros Tbk (THIGH), while PT Kalbe Farm Tbk (KLBF) is a private pharmaceutical issuer.
Wiku added that the government through the task force team formed a team of vaccine and drug experts to ensure vaccine candidates were made suitable to protect the people of Indonesia.
Wiku added that there are three requirements for this vaccine, which are safe, precise and fast. The point is safe is that the vaccine must be able to provide protection to the community and there are no side effects.
“While appropriate is the vaccine can provide specific immunity to protect the public from the corona virus,” said Wiku.
While fast, because of the conditions experienced by Indonesia, the government wants to quickly protect its people. The trick, accelerate clinical trials.
“So that the vaccine can be produced properly and in adequate quantities. We really want to be able to provide the vaccine to all Indonesian citizens,” he concluded.
(bag bag)
–
